title: Surgical versus conservative treatment in patients with cerebral cavernomas and non refractory epilepsy.
abstract: OBJECTIVE
  The optimal therapy of patients with cerebral cavernoma (CCs) and new onset epilepsy, sporadic seizures, or non well established refractory epilepsy is still not clear. The aim of this study was to compare the incidence of seizures in patients with CCs both operated and non operated, in order to obtain more information on the correct management of these patients.
  
  
  METHODS
  We studied retrospectively 43 patients with non refractory epilepsy secondary to CCs. Twenty-six of them (60.5%) underwent surgery and made up the surgical group, and 17 patients were treated medically and constituted the medical group. Seizure frequency and other clinical variables were compared between both groups.
  
  
  RESULTS
  At two years, out of the 26 operated patients, 19 (73%) remained seizure free, 4 (15%) had less than a seizure per month, and one patient (4%) had more than one seizure per month. At five years, 15 patients of the surgical group remained for analysis. Of them, 11 (73.3%) were seizure free, and 4 (26.7%) had less than one seizure a month. In the medical group, 12 out of 17 patients were seizure free (70.6%). There were no significant differences between the two groups (p=0.2 and p=0.3, respectively). Seven patients had postoperative neurological sequelae.
  
  
  CONCLUSIONS
  Surgical treatment of patients with non refractory epilepsy due to CCs did not significantly reduce the likelihood of seizures when compared to medical treatment. It must also be considered that surgery carries serious risks. A prospective and randomized study must be carried out to further clarify our findings.
authors.affiliation: Neurological Unit, Internal Medicine Service, Hospital Plató, Spain. santiago.fernandez@hospitalplato.com
authors.forename: Santiago
authors.initials: S
authors.lastname: Fernández
authors.forename: Júlia
authors.initials: J
authors.lastname: Miró
authors.forename: Mercé
authors.initials: M
authors.lastname: Falip
authors.forename: Alejandro
authors.initials: A
authors.lastname: Coello
authors.forename: Gerard
authors.initials: G
authors.lastname: Plans
authors.forename: Sara
authors.initials: S
authors.lastname: Castañer
authors.forename: Juan José
authors.initials: JJ
authors.lastname: Acebes
mesh_terms: D000328:Adult; D000368:Aged; D000927:Anticonvulsants / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000150:complications / Q000628:therapy*; D004827:Epilepsy / Q000209:etiology / Q000628:therapy*; D005260:Female; D020786:Hemangioma, Cavernous, Central Nervous System / Q000150:complications / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019635:Neurosurgical Procedures; D012189:Retrospective Studies; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000927:Anticonvulsants